Anagenics Limited (AU:AN1) has released an update.
Anagenics Limited reported a positive financial performance for Q4 FY24, with a 17% increase in customer cash receipts to $2.8M and a net improvement in operating cash flow by $0.7M compared to the previous quarter. The company also completed a share placement raising $1.2M and received a lumpsum cash settlement from a royalty agreement, continuing its growth trajectory in the health and beauty-tech sector.
For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.
